141 related articles for article (PubMed ID: 7286886)
21. Extrasellar prolactinomas: successful management of 24 patients using bromocriptine.
Sieck JO; Niles NL; Jinkins JR; Al-Mefty O; el-Akkad S; Woodhouse N
Horm Res; 1986; 23(3):167-76. PubMed ID: 3949288
[TBL] [Abstract][Full Text] [Related]
22. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
Thorner MO; Martin WH; Rogol AD; Morris JL; Perryman RL; Conway BP; Howards SS; Wolfman MG; MacLeod RM
J Clin Endocrinol Metab; 1980 Sep; 51(3):438-45. PubMed ID: 6773972
[TBL] [Abstract][Full Text] [Related]
23. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
[TBL] [Abstract][Full Text] [Related]
24. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
[TBL] [Abstract][Full Text] [Related]
25. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
Ahmed M; al-Dossary E; Woodhouse NJ
Fertil Steril; 1992 Sep; 58(3):492-7. PubMed ID: 1521641
[TBL] [Abstract][Full Text] [Related]
26. Bromocriptine for visual field defects in prolactinomas.
Mustaffa Embong ; Satgunasingam N; Sabri M Rejab ; Hardeep Singh
Med J Malaysia; 1981 Mar; 36(1):29-36. PubMed ID: 7321934
[No Abstract] [Full Text] [Related]
27. [Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
Fossati P; Grenier JL; Stevenard C; Fermon C; Christiaens JL; Linquette M
Ann Med Interne (Paris); 1982; 133(1):45-7. PubMed ID: 7065588
[TBL] [Abstract][Full Text] [Related]
28. Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.
Verde G; Oppizzi G; Chiodini PG; Dallabonzana D; Luccarelli G; Liuzzi A
J Endocrinol Invest; 1985 Apr; 8(2):113-5. PubMed ID: 4031376
[TBL] [Abstract][Full Text] [Related]
29. Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
Ayers JW
Fertil Steril; 1983 Dec; 40(6):846-8. PubMed ID: 6653805
[No Abstract] [Full Text] [Related]
30. Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?
Landolt AM; Osterwalder V
J Clin Endocrinol Metab; 1984 Jun; 58(6):1179-83. PubMed ID: 6725514
[TBL] [Abstract][Full Text] [Related]
31. A young man with visual defect and galactorrhea.
Thorner MO
Hosp Pract (Off Ed); 1982 Aug; 17(8):122L, 122P, 122T passim. PubMed ID: 6807806
[No Abstract] [Full Text] [Related]
32. Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptine.
Chakera TM; Khangure MS; Pullen P
Clin Radiol; 1985 May; 36(3):223-6. PubMed ID: 4064503
[TBL] [Abstract][Full Text] [Related]
33. Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male.
Ayalon D; Eckstein N; Homonnai ZT; Paz GF; Eshel A; Reider I
Int J Gynaecol Obstet; 1982 Dec; 20(6):481-5. PubMed ID: 6130996
[TBL] [Abstract][Full Text] [Related]
34. Reduction in size of a pituitary tumor by bromocriptine therapy.
McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
[No Abstract] [Full Text] [Related]
35. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
[TBL] [Abstract][Full Text] [Related]
36. Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients.
Jamrozik SI; Bennet AP; James-Deidier A; Tremollieres F; Saint-Martin F; Dumoulin S; Valat-Coustols M; de Glisezinski I; Tremoulet M; Manelfe C; Louvet JP
J Endocrinol Invest; 1996; 19(7):472-9. PubMed ID: 8884542
[TBL] [Abstract][Full Text] [Related]
37. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.
Dietemann JL; Portha C; Cattin F; Mollet E; Bonneville JF
Neuroradiology; 1983; 25(3):133-8. PubMed ID: 6888713
[TBL] [Abstract][Full Text] [Related]
38. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
Galvan G; Frick J; Irnberger T
Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
[TBL] [Abstract][Full Text] [Related]
39. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
40. Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
Schatz H; Stracke H; Hildebrandt G
Pathol Res Pract; 1988 Sep; 183(5):546-51. PubMed ID: 3237541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
